Resumo

COLUMBIE REGUEIFEROS, Justa Carmen et al. Use of the vaccine CIMAvax-EGF^® as habitual medical practice. MEDISAN [online]. 2019, vol.23, n.2, pp. 219-231. ISSN 1029-3019.

A descriptive and longitudinal study of 58 patients with lung cancer of non small cells, assisted in the service of Lung Shades corresponding to the Pneumology Service of Dr. Juan Bruno Zayas Alfonso Teaching General Hospital was carried out in Santiago de Cuba, from January, 2013 to the same month of 2018, who were treated with CIMAvax-EGF® as habitual medical practice, with the aim of determining the clinical and epidemiological characteristics of them. The male sex and ages from 60 to 79 years prevailed in the series; also, stage IV of the disease and the adenocarcinoma as histological variety were more frequent. With the use of the vaccine most of the patients presented a survival of 12.9 months and a therapeutic response of the non progressive disease.

Palavras-chave : lung cancer; non small cells lung cancer; anticancerous vaccines; CIMAvax-EGF^®; Pneumology Service.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )